{"title":"Informed Consent Forms for Research with Human Subjects: Time to End the Charade.","authors":"Leonard H Glantz","doi":"10.1017/amj.2025.6","DOIUrl":null,"url":null,"abstract":"<p><p>In 1974, the Center for Law and Health Sciences at the Boston University School of Law provided legal background papers on informed consent to research to the newly created National Commission for the Protection of Human Subjects of Biomedical and Behavioral Sciences. These papers were written by George J. Annas, the Center's Director, as well as Barbara F. Katz and I, who were staff attorneys at the time. These papers can be found in the appendices to the Commission reports<sup>1</sup> and in our book <i>Informed Consent to Human Experimentation: The Subject's Dilemma</i>,<sup>2</sup> in which we present a refined version of those papers. This project introduced me to the world of human research ethics and the complexities of protecting the rights and welfare of research subjects.<sup>3</sup> Over the past fifty years, I have sat on Institutional Review Boards (IRBs), been a member of the FDA's Pediatric Research Advisory Board, and engaged in varying activities related to human subject protection. During this time, I took for granted that consent forms were the best method for ensuring that subjects were thoroughly informed about all aspects of the proposed research. Like many IRB members, I spent considerable time reviewing, editing, and debating with other IRB members about the precise wording of these forms.</p>","PeriodicalId":7680,"journal":{"name":"American Journal of Law & Medicine","volume":"50 3-4","pages":"204-221"},"PeriodicalIF":0.5000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Law & Medicine","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.1017/amj.2025.6","RegionNum":4,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/24 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"LAW","Score":null,"Total":0}
引用次数: 0
Abstract
In 1974, the Center for Law and Health Sciences at the Boston University School of Law provided legal background papers on informed consent to research to the newly created National Commission for the Protection of Human Subjects of Biomedical and Behavioral Sciences. These papers were written by George J. Annas, the Center's Director, as well as Barbara F. Katz and I, who were staff attorneys at the time. These papers can be found in the appendices to the Commission reports1 and in our book Informed Consent to Human Experimentation: The Subject's Dilemma,2 in which we present a refined version of those papers. This project introduced me to the world of human research ethics and the complexities of protecting the rights and welfare of research subjects.3 Over the past fifty years, I have sat on Institutional Review Boards (IRBs), been a member of the FDA's Pediatric Research Advisory Board, and engaged in varying activities related to human subject protection. During this time, I took for granted that consent forms were the best method for ensuring that subjects were thoroughly informed about all aspects of the proposed research. Like many IRB members, I spent considerable time reviewing, editing, and debating with other IRB members about the precise wording of these forms.
1974年,波士顿大学法学院的法律和健康科学中心向新成立的保护生物医学和行为科学人类受试者国家委员会提供了关于研究知情同意的法律背景文件。这些论文是由中心主任乔治·j·安纳斯(George J. Annas)、芭芭拉·f·卡茨(Barbara F. Katz)和我撰写的,我们当时是中心的专职律师。这些论文可以在委员会报告的附录1和我们的《人体实验的知情同意:受试者的困境》一书中找到,在这本书中,我们对这些论文进行了提炼。这个项目把我带到了人类研究伦理的世界,以及保护研究对象权利和福利的复杂性在过去的50年里,我在机构审查委员会(irb)任职,是FDA儿科研究咨询委员会的成员,并从事与人类受试者保护有关的各种活动。在这段时间里,我理所当然地认为,同意书是确保受试者完全了解拟议研究的各个方面的最佳方法。像许多IRB成员一样,我花了相当多的时间审查、编辑和与其他IRB成员讨论这些表单的精确措辞。
期刊介绍:
desde Enero 2004 Último Numero: Octubre 2008 AJLM will solicit blind comments from expert peer reviewers, including faculty members of our editorial board, as well as from other preeminent health law and public policy academics and professionals from across the country and around the world.